Search Results

Now showing 1 - 1 of 1

Add to my favorites
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
(Elsevier, 2021) Muñoz-Martínez, S. (Sergio); Sapena, V. (Victor); Forner, A. (Alejandro); Nault, J.C. (Jean-Charles); Sapisochin, G. (Gonzalo); Rimassa, L. (Lorenza); Sangro, B. (Bruno); Bruix, J. (Jordi); Sanduzzi-Zamparelli, M. (Marco); Holówko, W. (Waclaw); Kassas, M. (Mohamed) El; Mocan, T. (Tudor); Merle, P. (Philippe); Hoogwater, F.J.H. (Frederik J.H.); Alqahtani, S.A. (Saleh A.); Reeves, H. (Helen); Pinato, D.J. (David J.); Giorgakis, E. (Emmanouil); Meyer, T. (Tim); Villadsen, G.E. (Gerda Elisabeth); Wege, H. (Henning); Salati, M. (Massimiliano); Mínguez, B. (Beatriz); Di-Costanzo, G.G. (Giovan Giuseppe); Roderburg, C. (Christoph); Tacke, F. (Frank); María Varela; Galle, P.R. (Peter R.); Alvares-da-Silva, M.R. (Mario Reis); Argemí, J. (Josepmaria)
The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems globally. Herein, we assessed the impact of the first wave pandemic on patients with liver cancer and found that routine care for these patients has been majorly disrupted, which could have a significant impact on outcomes.